Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study.

OBJECTIVE To decide the medical significance of the polymerase chain response (PCR)-reverse dot blot (RDB) human papillomavirus (HPV) genotyping assay in cervical most cancers screening. METHODS A complete of 10,442 women attending the Fujian Provincial Maternity and Children’s Health Hospital have been evaluated utilizing the liquid-based cytology (thinprep cytologic test [TCT]) and the PCR-RDB HPV … Read more

Read more

PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.

To consider the polymerase chain response (PCR)-reverse-dot-blot (RDB) human papillomavirus (HPV) genotyping test as a possible assay for the cervical cancer primary screening.In a hospital-based cohort, a complete of 21,568 ladies have been voluntarily enrolled from March 2009 to November 2016 for evaluating the three present cervical cancer screening methods: co-test, cytology primary and high-risk … Read more

Read more